IFNL4 genotype and other markers in the IFNL3/IFNL4 region have been linked with reduced hepatic inflammation and fibrosis, a pre-stage for cirrhosis (16, 17, 34), potentially mitigating progression to HCC. Here, IFNL4 is linked to hepatocellular carcinoma.